AI Article Synopsis
- The study evaluated the effectiveness and safety of low-molecular-weight heparins (LMWHs) for cancer patients at low risk of venous thromboembolism (VTE) over a 12-month period across 15 medical sites in Turkey.
- Among 250 patients, the majority completed follow-ups, with enoxaparin and bemiparin showing different efficacy levels; bemiparin demonstrated a significantly higher rate of thrombus resolution compared to enoxaparin.
- Only 2 patients stopped treatment due to gastrointestinal bleeding, indicating good overall tolerability of the LMWHs studied.
Article Abstract
We compared the efficacy and safety of low-molecular-weight heparins (LMWHs) in patients with cancer who are at low risk of venous thromboembolism (VTE). Patients were treated by medical oncologists in Turkey at 15 sites, where they were enrolled and followed up for a period of 12 months. Due to the study design, there was no specific treatment protocol for LMWH. Primary end points were efficacy and the time to change in VTE status. Of the included 250 patients, 239 (95.6%), 176 (70.4%), 130 (52.0%), and 91 (36.4%) completed their day 15, month 3, month 6, and month 12 visits, respectively. Number of patients treated with enoxaparin, bemiparin, and tinzaparin were 133, 112, and 5, respectively. Anticoagulant therapy provoked thrombus resolution in 1.2% and 12.7% of patients using enoxaparin and bemiparin, respectively ( P = .004). Thrombus resolution was observed in 81 more patients at month 3 visit. This ratio was 35 (40.2%) of 87 and 46 (54.1%) of 85 patients administered enoxaparin and bemiparin at the third visit, respectively ( P = .038). Thrombus resolution was observed in 21 more patients during month 6 visit. This ratio was 5 (7.7%) of 65 and 15 (23.4%) of 64 patients administered enoxaparin and bemiparin at the fourth visit, respectively ( P = .022). The LMWH was discontinued in only 2 patients due to gastrointestinal bleeding. This pioneering study shows bemiparin is more effective than enoxaparin in thrombosis resolution and has a similar tolerability profile.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714721 | PMC |
| http://dx.doi.org/10.1177/1076029617753538 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Factor Xa Inhibitors and Low Molecular Weight Heparins in Perioperative Surgical Thromboprophylaxis: A Network Meta-Analysis.
Cardiovasc Hematol Agents Med Chem
October 2024
Department of Community and Family Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, 249203, India.
Article Synopsis
- This study looked at ways to prevent blood clots during and after major surgeries, which is important because clots can be dangerous.
- Researchers compared different medications called factor Xa inhibitors and low molecular weight heparins (LMWHs) to see which ones worked best.
- They found that rivaroxaban, fondaparinux, edoxaban, and bemiparin were better than enoxaparin in preventing blood clots, but fondaparinux and bemiparin increased the risk of serious bleeding more than the others.
Exploring the use of electroconvulsive therapy in the anticoagulated population: A systematic review.
Aust N Z J Psychiatry
January 2025
Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.
Article Synopsis
- Electroconvulsive therapy (ECT) is effective for various psychiatric disorders, but there are concerns about its use in patients taking anticoagulants, prompting this systematic review to investigate potential adverse effects.
- The review analyzed data from multiple databases, focusing on studies involving 108 patients undergoing over 700 ECT sessions while on anticoagulation; most were on warfarin, with a couple of reports of bleeding incidents but no severe complications.
- Findings indicate that continuing anticoagulation during ECT is generally safe, as most patients experienced no significant side effects, although more research is needed due to limitations like the small number of studies and varying patient health conditions.
Bemiparin vs enoxaparin in the prevention of thrombosis in microvascular head and neck reconstruction.
J Plast Reconstr Aesthet Surg
August 2022
Department of Oral and Maxillofacial Surgery, Ramón y Cajal University Hospital, Madrid, Spain; University of Alcala de Henares, Madrid, Spain; Ramón y Cajal Research Institute (IRYCIS) Spain.
This study aims to compare the use of Bemiparin vs Enoxaparin in patients undergoing microvascular head and neck reconstruction, analyzing the incidence of flap thrombotic complications and local bleeding that could compromise the flap survival. This is an observational study on a group of 204 patients who underwent a microvascular flap for head and neck reconstruction at the Oral and Maxillofacial Surgery Department of Ramon y Cajal Hospital in Madrid, Spain. A group of 67 patients was treated according to a protocol for postoperative prophylaxis of thromboembolism with Bemiparin, which was compared with data collected retrospectively from a group of 137 patients treated with Enoxaparin.
View Article and Find Full Text PDFBullous haemorrhagic dermatitis induced by heparins and other anticoagulants: 94 cases from French pharmacovigilance centres and a literature review.
Ann Dermatol Venereol
March 2022
Clinique dermatologique, hôpitaux universitaires et université de Strasbourg, 1, place de l'Hôpital, 67091 Strasbourg, France. Electronic address:
Background: Bullous haemorrhagic dermatitis (BHD) is an uncommon and highly particular side effect of various forms of heparins.
Methods: To better characterise the disease, we collected all cases from French Pharmacovigilance centres recorded over a 20-year period (37 cases) and performed a Medline literature search up to June 2020 (57 cases).
Results: In all, 94 patients were identified (male/female ratio: 2.
Ranking the efficacy of anticoagulants for the prevention of venous thromboembolism after total hip or knee arthroplasty: A systematic review and a network meta-analysis.
Pharmacol Res
April 2021
School of Physical Education and Training, Shanghai University of Sport, No.650, Qingyuanhuan Rd., 200438, Shanghai Municipality, PR China. Electronic address:
Background: Anticoagulants are essential in the prevention of venous thromboembolism. However, the effectiveness and safety of different anticoagulants have always been controversial. Therefore, we aimed to expand the sample of anticoagulant results and rank the efficacy and safety of 19 anticoagulants in the prevention of venous thromboembolism when total knee or total hip arthroplasty procedure is performed.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!